Literature DB >> 7967998

Thrombocytopenic purpura after recombinant hepatitis B vaccine.

P Poullin, B Gabriel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967998     DOI: 10.1016/s0140-6736(94)90777-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Vaccine administration and the development of immune thrombocytopenic purpura in children.

Authors:  Valerio Cecinati; Nicola Principi; Letizia Brescia; Paola Giordano; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

3.  Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine.

Authors:  F Ronchi; P Cecchi; F Falcioni; A Marsciani; G Minak; G Muratori; P L Tazzari; S Beverini
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

Review 4.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

Review 5.  Hepatitis B vaccination and associated oral manifestations: a non-systematic review of literature and case reports.

Authors:  B Tarakji; N Ashok; R Alakeel; Sn Azzeghaibi; A Umair; S Darwish; Rs Mahmoud; E Elkhatat
Journal:  Ann Med Health Sci Res       Date:  2014-11

Review 6.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.